Nexus NeuroTech - Latest News and Investment Deals
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeNexus NeuroTech
Nexus NeuroTech logo

Nexus NeuroTech

0 followers

About Nexus NeuroTech

Nexus NeuroTech Ventures is a venture capital firm committed to advancing breakthrough technologies for brain disorders, such as Parkinson’s disease, bipolar disorder, and autism. They focus on investing in solutions that hold the greatest promise to help people with neurological and psychiatric disorders.

Recent News

No recent news for this company.

Recent Deals

Key Team Members

William J. Marks, Jr.

General Partner & Co-Founder

John Propst, PhD, MBA

Head of Incubator Operations

Jon Lundt

Principal

Edward Ruppel III

Senior Associate

Jordi Parramon

General Partner & Co-Founder

Key Facts

HQ Location

San Francisco, United States

Founded

2023

Employees

1 - 10

Status

Investor

Investor Type

Venture Investor

Website

https://nexusneurotech.com